[Ip-health] TOWARDS A HEALTH R&D CONVENTION Opportunities, Challenges and the way ahead

Ruth Lopert ruth.lopert at gmail.com
Mon Jul 9 08:30:41 PDT 2012


Can I suggest that when items like this are posted that the poster indicate
the address and the city and country in which they are being held? Just a
thought

On Mon, Jul 9, 2012 at 9:11 AM, Gopa Kumar <kumargopakm at gmail.com> wrote:

> *TOWARDS A HEALTH R&D CONVENTION *
>
> *Opportunities, Challenges and the way ahead *
>
> *Workshop by Third World Network (TWN) & Drugs for Neglected Diseases
> Initiative (DNDi)*
>
> *When: Monday, July 9, 17.00 p.m.*
>
> *Venue: Room C5*
>
>
>
> At this 3rd Peoples Health Assembly, Third World Network (TWN) and Drugs
> for Neglected Diseases Initiative (DNDi) are hosting a workshop on the
> *negotiations
> for a convention on health R&D to address the health needs of developing
> countries*.
>
>
>
> TWN and DNDi would like to invite participants at the PHA to a civil
> society briefing on the issue and the need to engage in this ambitious
> dream for a R&D system for developing countries.
>
>
>
> *Speakers: *
>
>
>
> Amitava Guha (Chair), Sangeeta Shashikant (TWN), Pascale Boulet (DNDi), Tim
> Reed (Health Action International) Leena Menghaney (MSF Access Campaign).
> Followed by Questions and panel discussion
>
>
>
> *Background:* The vast majority of health products are developed with a
> research bias to respond to the needs of patients in developed countries.
> This corresponds to unequal access to treatment for patients in developing
> countries driven by a 10/90 R&D gap.  Less than 10 % of all health research
> is devoted to the health of 90 % of the world population, which results in
> neglected diseases and neglected patients.
>
>
>
> This is a reflection of the currently IP driven and highly privatized R&D
> system which in the absence of market incentives fails to put resources and
> focus into research and development (R&D) geared towards resource poor
> countries and the needs of their people.
>
>
>
> Ten years ago, WHO started a crucial discussion about how to ensure that
> medical innovation could also be geared toward the medical needs of people
> in developing countries, rather than continue to be driven by commercial
> incentives only. Finally, a WHO ‘Consultative Expert Working Group’ (CEWG)
> in April 2012 published a high level report containing a series of
> recommendations, among them a proposal that WHO Member States begin a
> process towards establishing a convention on health R&D to address the
> health needs of developing countries, under Article 19 of the WHO
> Constitution.
>
>
>
> Civil society and developing governments do have an opportunity to get the
> ambitious dream of the ‘need based R&D convention’ back on the agenda
> before the 2013 Executive Board in January and the World Health Assembly
> later in May 2013.
>
>
>
> *This workshop is aimed at:* providing a briefing on the issue; involving
> the health movement across the world in the debates around the convention
> on health R&D; and highlighting the different negotiating positions of
> member states of the WHO.
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>



More information about the Ip-health mailing list